Vedanta  shares  down  0.16% as Sensex  rises

A total of 269,049 shares changed hands on the counter till 01:55PM (IST)

Shares of . fell 0.16 per cent to Rs 266.55 in Wednesday's session as of 01:55PM (IST) even as the equity benchmark traded 219.17 points higher at 72231.22.

Earlier in the day, the stock witnessed a gap up start to the session. The stock quoted a 52-week high price of Rs 301.0 and a 52-week low of Rs 207.85 on . Around 269049 shares changed hands on the counter till 01:55PM (IST).

The stock opened at Rs 267.5 and has touched an intraday high and low of Rs 269.95 and Rs 261.8 during the session so far. The scrip quoted a price-to-earnings (PE) ratio of 20.87, earnings per share (EPS) of Rs 12.78 and price to book value (PB) of 2.59, while the return on equity (ROE) stood at Rs 26.82.

Promoter/ FII Holding
The promoters held 63.71 per cent stake in the company as of March 20, while FII and MF ownerships stood at 7.74 per cent and 1.42 per cent, respectively.

Key Financials
With a market capitalisation of Rs 99137.89 crore, the company operates in the Diversified industry. For the quarter ended 31-Dec-2023, the company reported consolidated sales of Rs 36320.0 crore, down 8.25 per cent from the previous quarter?s Rs 39585.0 crore and down 4.31 per cent from the same quarter a year ago. The company reported net profit of Rs 2013.0 crore for the latest quarter, down 18.3 per cent from the corresponding quarter last year.

Technical Indicators
The relative strength index (RSI) of the stock stands at 47.76. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.

Source: Stocks-Markets-Economic Times

Останні публікації
Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps
20.09.2024 - 18:00
RBC says this stock is a 'top mid-cap cybersecurity idea,' starts coverage at Buy
20.09.2024 - 18:00
Ryman Hospitality Properties director sells $96,588 in company stock
20.09.2024 - 18:00
Trump Media shares drop after lock-up expires
20.09.2024 - 18:00
ECB Bancorp CFO acquires $69.9k in company stock
20.09.2024 - 18:00
Earnings call: Alliance Entertainment announces mixed FY 2024 results
20.09.2024 - 18:00
Fed's relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports
20.09.2024 - 18:00
Nike veteran Hill to replace Donahoe as CEO; shares jump  
20.09.2024 - 18:00
Novo Nordisk shares drop more than 4% on disappointing obesity pill data
20.09.2024 - 18:00
Johnson Controls EVP and CFO sells $13.7k in stock
20.09.2024 - 18:00
'Temu Threat Abating in 2Q24' - Barclays
20.09.2024 - 18:00
Here's why BTIG says they would be "patient buyers" after large Fed rate cut
20.09.2024 - 18:00
US FDA approves Zevra's treatment for rare genetic disease
20.09.2024 - 18:00
Premier Inc. CFO Craig McKasson sells $204,100 worth of shares
20.09.2024 - 18:00
Earnings call: iPower reports mixed results, optimistic about 2025
20.09.2024 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз трейдера Аналіз трейдера за 20.09.24
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.